74
Participants
Start Date
April 17, 2023
Primary Completion Date
November 30, 2025
Study Completion Date
November 30, 2025
bilateral superficial cervical plexus blocks and local wound infiltration
10mL bupivacaine at Erb's point bilaterally and 10mL 0.25% Bupicacaine at incision
placebo injection and local wound infiltration
10mL normal saline at Erb's point bilaterally and 10mL 0.25% Bupicacaine at incision
RECRUITING
UC Davis Medical Center, Sacramento
University of California, Davis
OTHER